The current targets of successful IBD therapies are the following: healing of the intestinal ulcers, resolution of rectal bleeding and abdominal pain, normalization of bowel habits, and significant improvement of the IBD patients’ quality of life so that they can “return to Society” as productive individuals. These results are achieved in approximately 55-60% of adequately treated patients.